Early and late therapy response assessment with [18F] fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: Analysis of a prospective multicenter trial

130Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Purpose: In adult Hodgkin's lymphoma (HL) risk stratification after early therapy response assessment with [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) seems to allow tailoring therapy with less toxicity for patients with adequate metabolic response. This study delivers the first prospective data on the potential of FDG-PET for response assessment in pediatric HL. Patients and Methods: FDG-PET was performed in 40 pediatric HL patients before polychemotherapy (PET-1), after two cycles of polychemotherapy (PET-2), and after completion of polychemotherapy (PET-3). Mean follow-up was 46 months (range, 26 to 72 months). Results: At early and late response assessment, the proportion of PET-negative patients was significantly higher compared with those patients with negative findings in conventional imaging methods (CIMs; PET-2, 26 of 40 v CIM-2, one of 40; P < .001; PET-3, 21 of 29 v CIM-3, four of 29; P < .001). Specificity of early therapy response assessment by PET was improved to 97% by quantitative analysis of maximal standardized uptake value reduction using a cutoff value of 58%. Conclusion: Pediatric HL patients with a negative PET in response assessment have an excellent prognosis while PET-positive patients have an increased risk for relapse. © 2009 by American Society of Clinical Oncology.

References Powered by Scopus

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas

3370Citations
N/AReaders
Get full text

A prognostic score for advanced Hodgkin's disease

1568Citations
N/AReaders
Get full text

Use of positron emission tomography for response assessment of lymphoma: Consensus of the imaging subcommittee of international harmonization project in lymphoma

1237Citations
N/AReaders
Get full text

Cited by Powered by Scopus

<sup>18</sup>F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging

126Citations
N/AReaders
Get full text

qPET - A quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma

122Citations
N/AReaders
Get full text

PET and MR imaging: The odd couple or a match made in heaven?

115Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Furth, C., Steffen, I. G., Amthauer, H., Ruf, J., Misch, D., Schönberger, S., … Hundsdoerfer, P. (2009). Early and late therapy response assessment with [18F] fluorodeoxyglucose positron emission tomography in pediatric Hodgkin’s lymphoma: Analysis of a prospective multicenter trial. Journal of Clinical Oncology, 27(26), 4385–4391. https://doi.org/10.1200/JCO.2008.19.7814

Readers over time

‘10‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

48%

Researcher 8

24%

Professor / Associate Prof. 7

21%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 33

89%

Computer Science 2

5%

Agricultural and Biological Sciences 1

3%

Physics and Astronomy 1

3%

Save time finding and organizing research with Mendeley

Sign up for free
0